When was CariCord founded?

CariCord was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is CariCord located?

CariCord is headquartered in Aurora, United States.

How many employees does CariCord have?

As of May 31, 2026, the latest employee count at CariCord is 6.

Is CariCord a funded company?

CariCord is a funded company, having raised a total of $550K across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 17, 2014.

When was the latest funding round of CariCord?

CariCord's latest funding was a $***** Conventional Debt round on Mar 21, 2018, with participation from 0 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $829M in funding in 2026 to date.

Where does CariCord rank among its competitors?

CariCord ranks 26th amongst 41 active competitors, of which 2 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was LifeCell, which secured $22.1M in Mar, 2024.

Who are the top competitors of CariCord?

CariCord's top competitors include Cordlife, LifeCell and Green crosscell. Among them, LifeCell secured the most recent funding round in March, 2024.

CariCord - 2026 Company Profile, Funding & Competitors

CariCord is an acqui-hired company based in Aurora (United States), founded in 2013. It operates as a Cord blood and placental banking for newborn stem cell therapies. CariCord has raised $550K in funding. The company has 41 active competitors, including 2 funded and 10 that have exited. Its top competitors include companies like Cordlife, LifeCell and Green crosscell.

Company Details

Cord blood and placental banking for newborn stem cell therapies. They specialize in the collection, processing, and storage of cord blood, placental tissue, and placental blood, rich sources of hematopoietic and mesenchymal stem cells. These cells offer potential applications in cellular and regenerative medicine, with cord blood stem cells FDA-approved to treat numerous diseases. The company utilizes patented processing methods to ensure the quality and availability of stem cells for future family use. They provide options for preserving stem cells, offering peace of mind for families seeking to improve their health. Services include pricing and packages, a donation program, and resources like a quick guide, planning sessions, and enrollment. They focus on family's hopes and dreams for a healthy future.

Website: caricord.com
Social
Email ID: *****@caricord.com

Key Metrics

Founded Year

2013

Location

Aurora, United States

Stage

Acqui-Hired

Total Funding

$550K in 3 rounds

Latest Funding Round

Conventional Debt, Mar 21, 2018, $*****

Ranked

26^th among 41 active competitors

Employee Count

6 as on May 31, 2026

Similar Companies

Cordlife & 46 more

View CariCord's full profile

CariCord is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CariCord, Inc. CIN: 463927893 , United States, Active		$1M - $5M (As on Oct 13, 2015)	-	-

CariCord has raised a total funding of $550K over 3 rounds. Its first funding round was on Apr 17, 2014.

Here is the list of recent funding rounds of CariCord:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 21, 2018	4043566	Conventional Debt	9331362	6194862	9372158	6286612
Oct 13, 2015	3922868	Seed	7670001	6170773	2872254	5953099
Apr 17, 2014	6477568	Seed	3807924	5225613	8339387	2370253

Access funding benchmarks and valuations. Sign up today!

View details of CariCord's funding rounds and investors

CariCord's employee count trend

CariCord has 6 employees as of May 26. Here is CariCord's employee count trend over the years:

Uncover CariCord's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CariCord include Cordlife, LifeCell and Green crosscell. Here is the list of Top 10 competitors of CariCord, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cordlife 2001, Singapore (Singapore), Public	Provider of cord blood and cord lining banking and newborn metabolic screening	$7M	UOB, APC Investors & 2 others	69/100
2nd	LifeCell 2004, Chennai (India), Series B	A stem cell banking company specializing in cord blood and tissue preservation	$61.2M	Orbimed, Helion Venture Partners & 74 others	65/100
3rd	Green crosscell 1992, Seoul (South Korea), Public	Immunotherapy products and cryopreservation of cord blood	-	-	45/100
4th	ViaCord 1993, Hebron (United States), Acquired	Provider of services for cord blood and stem cell banking	$84.5M	Phase4 Partners, Tullis Health Investors & 9 others	45/100
5th	Cordlife India 2001, Kolkata (India), Unfunded	Provider of cord blood banking services	-	-	43/100
6th	CORD:USE Cord Blood 2004, Orlando (United States), Acquired	Provider of umbilical cord blood stem cell storage services	$27M	-	40/100
7th	Cellaviva 2014, Huddinge (Sweden), Public	Long term storage of umbilical cord stem cells	-	-	37/100
8th	International Stemcell Services 2008, Bengaluru (India), Seed	Provides storage of human adult stem cells	$84.2K	HealthCare Global Enterprises, Cryo Stemcell ... & 6 others	35/100
9th	Cryoviva 2006, Gurugram (India), Unfunded	Indian multinational cord blood bank, providing umbilical cord blood stem cell processing and storage.	-	-	33/100
10th	Cell Care 2009, Moorabbin (Australia), Acquired	Provider of services in cord blood biobanking	-	-	33/100
26th	CariCord 2013, Aurora (United States), Acqui-Hired	Cord blood and placental banking for newborn stem cell therapies	$550K	-	24/100